Feature

The EU approved Gilead’s HIV prevention injection, Yeytuo. Learn how it works and why it could reshape global PrEP strategies.

Lenacapavir offers twice-yearly HIV prevention, but barriers like cost and insurance access raise global equity concerns.

Learn how to date with HIV in 2025 with confidence. Explore tips for disclosure, safety, and building healthy relationships.

Explore the latest HIV and AIDS research in 2025, from vaccines to long-acting treatments. Discover what science is tackling next.

HIV education in 2025 empowers communities. Learn what’s new, what works, and why knowledge is still our best tool.

Learn how the U=U campaign in 2025 is changing HIV awareness. Undetectable equals untransmittable—here’s why it’s a game-changer.

HIV and depression often go hand in hand. In 2025, mental health care is key to holistic HIV treatment. Learn more about symptoms and support.

AIDS funding cuts in 2025 are disrupting global care. Learn how these changes affect prevention, treatment, and vulnerable communities.

Explore the top HIV prevention drugs in 2025. Learn how PrEP, injectables, and new options are protecting more people than ever.

Learn the key HIV symptoms to watch for in 2025. Know what signs to take seriously and when to get tested.